Synthetic cannabinoid receptor agonists: Analytical profiles and development of QMPSB, QMMSB, QMPCB, 2F‐QMPSB, QMiPSB, and SGT‐233-Reference-Cited by-同舟云学术

Synthetic cannabinoid receptor agonists: Analytical profiles and development of QMPSB, QMMSB, QMPCB, 2F‐QMPSB, QMiPSB, and SGT‐233

Published:2020-09-22 Issue:1 Volume:13 Page:175-196
ISSN:1942-7603
Container-title:Drug Testing and Analysis
language:en
Short-container-title:Drug Test Anal

Author:

Brandt Simon D.¹^ORCID,Kavanagh Pierce V.²^ORCID,Westphal Folker³^ORCID,Dreiseitel Wolfgang⁴,Dowling Geraldine²⁵^ORCID,Bowden Matthew J.⁶,Williamson James P.B.⁷

Affiliation:

1. School of Pharmacy and Biomolecular Sciences Liverpool John Moores University Liverpool UK

2. Department of Pharmacology and Therapeutics, School of Medicine, Trinity Centre for Health Sciences St. James Hospital Dublin Ireland

3. Section Narcotics/Toxicology State Bureau of Criminal Investigation Schleswig‐Holstein Kiel Germany

4. Hessian State Bureau of Criminal Investigation Wiesbaden Germany

5. Department of Life Sciences School of Science, Sligo Institute of Technology Ash Lane Sligo Ireland

6. Stargate International Auckland New Zealand

7. Synex Synthetics BV Maastricht The Netherlands

Publisher

Wiley

Subject

Spectroscopy,Pharmaceutical Science,Environmental Chemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dta.2913

Reference63 articles.

1. BellMR.Sterling drug Inc. New York USA. 3‐Arylcarbonyl‐ and 3‐cycloalkylcarbonyl‐1‐aminoalkyl‐1H‐indoles compositions and use. US4581354A;1986.

2. D'AmbraTE BellMR.Sterling Drubg Inc. New York USA. 2‐ and 3‐Aminomethyl‐6‐arylcarbonyl‐2 3‐dihydropyrrolo[1 2 3‐de]‐1 4‐benzoxazines. US4939138A;1990.

3. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).Synthetic cannabinoids in Europe (perspectives on drugs). EMCDDA Lisbon 2017. Available at:http://www.emcdda.europa.eu/system/files/publications/2753/POD_Syntheticcannabinoids_0.pdf[Accessed 31 March 2020].

4. On a New Cannabinoid Classification System: A Sight on the Illegal Market of Novel Psychoactive Substances

5. Recent Developments in the Medicinal Chemistry of Cannabimimetic Indoles, Pyrroles and Indenes

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro characterization of the pyrazole-carrying synthetic cannabinoid receptor agonist 5F-3,5-AB-PFUPPYCA and its structural analogs;Forensic Science International;2023-02

2. Interpol Review of Drug Analysis 2019-2022;Forensic Science International: Synergy;2023

3. In vitro metabolic fate of the synthetic cannabinoid receptor agonists (quinolin‐8‐yl 4‐methyl‐3‐(morpholine‐4‐sulfonyl)benzoate [QMMSB]) and (quinolin‐8‐yl 4‐methyl‐3‐((propan‐2‐yl)sulfamoyl)benzoate [QMiPSB]) including isozyme mapping and carboxylesterases activity testing;Drug Testing and Analysis;2022-10-26

4. In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists 2F-QMPSB and SGT-233 Including Isozyme Mapping and Carboxylesterases Activity Testing;Journal of Analytical Toxicology;2022-09-09

5. Characterization of new psychoactive substances by integrating benchtop NMR to multi‐technique databases;Drug Testing and Analysis;2022-06-26